Personalized blood biopsies may provide signal of cancer recurrence – Harvard Gazette
Risk of loco-regional recurrence and distant metastases of patients with invasive breast cancer up to ten years after diagnosis – results from a registry-based study from Germany | BMC Cancer | Full
Signatera Overview | Natera
Monitoring breast cancer progression and response to therapy using... | Download Scientific Diagram
Longterm Followup of Breast Cancer Patients Julie R
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer | Science Translational Medicine
Breast cancer
Breast cancer recurrence rate not up with autologous fat transfer
Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time? - Cancer Treatment Reviews
Patient monitoring of treatment response of her sixth breast cancer... | Download Scientific Diagram
Follow-Up of Patients with Breast Cancer: Imaging of Local Recurrence and Distant Metastases | SpringerLink
Progression of breast cancer following locoregional ipsilateral recurrence: importance of interval time | British Journal of Cancer
PLOS ONE: Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast Cancer
Surveillance Breast MRI and Mammography: Comparison in Women with a Personal History of Breast Cancer | Radiology
Ask the Experts About Circulating Tumor DNA in the Management of Cancer - CancerConnect
The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS) | BMJ Open
:max_bytes(150000):strip_icc()/breast-cancer-tumor-markers-and-tumor-marker-tests-4301102-30358af146c64584b345c51499c0d70c.png "Breast Cancer Tumor-Marker Tests")
Breast Cancer Tumor-Marker Tests
2-PREVENT Breast Cancer TCE | Penn Medicine | Philadelphia, PA
PLOS ONE: Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast Cancer
Is a comparative clinical trial for breast cancer tumor markers to monitor disease recurrence warranted? A value of information analysis | Journal of Comparative Effectiveness Research
Tumor Markers of Breast Cancer: Role in Early Diagnosis, Monitoring Response to Therapy and Determination of Prognosis : Science and Education Publishing
Liquid Biopsy in Breast Cancer: A Comprehensive Review
New Strategies in Metastatic Hormone Receptor–Positive Breast Cancer: Searching for Biomarkers to Tailor Endocrine and Other Targeted Therapies | Clinical Cancer Research
7 new breakthroughs in breast cancer research | MDLinx
Breast cancer biomarkers tag
PLOS ONE: Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast Cancer
